ÂÜÀòÂÒÂ×

Jonathan Fitzsimmons is an experienced professional in the field of radiochemistry and analytical chemistry, currently serving as the Head of Radiochemistry and Associate Director of Analytical Chemistry at Curium Pharma since May 2020. Jonathan's prior roles include Medical Scientist at Brookhaven National Laboratory, where significant work involved the separation of thorium from Ac-225, and Research Associate at the University of North Carolina at Chapel Hill, focusing on radionuclide decorporation agents. Additionally, Jonathan has been a Post Doc at Los Alamos National Lab, automating chemical separations, and has held various research and teaching assistant positions in esteemed institutions. Jonathan holds a Ph.D. in Radiochemistry from the University of Missouri-Columbia, a Master's in Health Science from Johns Hopkins University, and a B.S. in Chemistry and Biology from Geneva College.